ARCHIVES

NCI CTEP-Approved Trials For the Month of September

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Technology Transfer Is Theme For 1990s, Broder Tells Writers; Laszio Offers Predictions On Treatment Advances

April 6, 1990

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014